Oncotarget has recently gained a large fan base courtesy of its free-access-to-all publication platform. In essence, oncotarget is a multidisciplinary journal platform that publishes journals on a weekly basis. Fortunately, each paper can be printed on demand by the reader. As a pioneer in the field, Oncotarget aims at making scientific results much readily available to users worldwide. More importantly, the online publication platform sensitizes on the need to have consultative discussions between researchers and editors with the sole intention of promoting high-quality research.
By using Oncotarget, readers are exempted from trivial borders that inhibit efficient transformation of knowledge. Despite its highly acclaimed benefits, Oncotarget specializes on courses about biomedical science with a keen perception of promoting scientific research. With such a platform, clinical science efforts to combat diseases are significantly boosted by the presence of modern technology. Unlike other sources, the insightful leadership behind Oncotarget’s rise to prominence has gone above and beyond to eliminate any logistical challenges that might arise in the course of service delivery. Download output styles at Endnote.com.
Oncotarget is currently accepting research articles on topics ranging from Metabolism, Pharmacology, Cell Biology, Neuroscience, Cardiology and Endocrinology. Oncotarget’s resounding success could not have been possible without the immense contribution of skilled editors with an eye for detail and perfection. For instance, Mikhail Blagosklonny and Andrei Gudkov, editors-in-chief and members of the Roswell Park Cancer Institute, have dedicated considerable time to polish submitted journals and ensure that they are at par with set standards. Several members of the elite team such as Frederick Alt, Dario Altieri, Stephen Baylin and Jiri Bartek have also played an integral role in the refinement of submitted articles for review.
An in-Depth Review of Studied Sections
Gerotarget: Also known as aging, this field focuses on aging-related research including pharmacological and dietary anti-aging modalities, genetics, metabolic syndrome and hypertension.
Pathology beyond oncology: This section lays adequate emphasis on pathology journals with a special interest in areas such as higher impact factor and ultra-rapid publication. Articles can only be submitted to the public after five days of intense evaluation.
Immunology and Microbiology: Under this section, a critical emphasis is placed on primary areas of research such immune cell development, gene regulation, microbiology and immunotherapy. Follow Oncotarget journal on Twitter.